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Abstract
Purpose To investigate the behavior of rotator cuff tears
treated with conventional repair technique with the aid of
autologous bone marrow mononuclear cells (BMMC).
Methods Fourteen consecutive patients (9 women, 5 men,
mean age of 59.2 years) with complete rotator cuff tears
(mean preoperative UCLA score of 12 ± 3.0) were ﬁxed
by transosseous stitches through mini-open incision, with
subsequent injection of BMMC into the tendon borders,
obtained from the iliac crest just prior to surgery. Magnetic
resonance images (MRI) were acquired before and after
surgery and evaluated by two musculoskeletal radiologists
regarding new postoperative ﬁndings of patients treated
with BMMC.
Results After a minimum 12-month follow-up period, the
UCLA score increased from 12 ± 3.0 to 31 ± 3.2. Clinical
ﬁndingsremainedunalteredinthefollowingyearinallbutone
patient (13/14). MRI analysis after a 12-month follow-up
period demonstrated tendon integrity in all cases (14/14),
presenceoflow-signalintensityareasalongthesupraspinatus
tendon and distal muscle belly in 8 cases (8/14), and high-
intensity blooming small round artifact at the bursal and ten-
don topography in 11 cases (11/14). Six patients (6/14)
showedformationofahigh-signalintensityzoneatthecritical
zone. Clinical ﬁndings remained unaltered in the following
year in all but one patient, who relapsed into loss of strength
and pain, being considered a bad result.
Conclusion Implantation of BMMC in rotator cuff
sutures appears to be a safe and promising alternative to
other biological approaches currently used to enhance tis-
sue quality in affected tendons.
Level of evidence IV.
Keywords Rotator cuff  Bone marrow mononuclear
cells
Introduction
The ﬁrst repair of rotator cuff injury is attributed to
Codman in 1911 [8]. However, little has changed in the
philosophy of treatment since Neer, in 1972, who proposed
simultaneous subacromial decompression by means of
osteotomy of the acromion and suture of injured tendons
[33].
The introduction of anchors [17] has facilitated tendon
reintegration near the bone, while synthetic non-absorbable
suture signiﬁcantly increased its resistance [1]. With the
advent of arthroscopy, these procedures became increas-
ingly popular and widespread in the orthopedic community,
but none of these advances has brought signiﬁcant
improvement to the quality of postoperative results in
patients with large rotator cuff injuries: the overall rate of
rerupture over the ﬁrst postoperative year ranges from 25 to
65% depending on lesion extent [15, 22].
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decade of life [33], and in the majority of cases, they are
caused by tendon avascular degeneration [36], which is
also responsible for the high rate of postoperative retear.
A strategy aiming to revitalize the tendon structure through
cell therapy [6, 20, 21] is the natural step ahead sought by
many centers worldwide, once it would probably overcome
this complication by increasing tendon resistance to muscle
traction [7, 26, 30, 35].
Recent animal studies on the role of bone marrow
derived cells for the reconstruction of bone lesions have
suggested that it can be safely explored in humans [16, 24].
Speciﬁcally, some studies have suggested a role for
mononuclear cell therapy in osteonecrosis [23]. In addition,
the use of bioactive glass associated with autologous bone
marrow mononuclear cells (BMMC) has been successfully
tested in benign bone lesions [29] and knee cartilage
lesions [3, 10, 34].
The objective of the present study was to evaluate the
possible advantages for tendon recovery of implanting
autologous BMMC following transosseous suturing of the
rotator cuff.
Materials and methods
This pilot study included 14 consecutive patients with
rotator cuff injuries. Patients were diagnosed by clinical
examination, conventional radiograph, and magnetic reso-
nance imaging (MRI).
MRI was performed using a 1.5-T high-ﬁeld scanner,
closed bore (HD Excite, GE, Milwaukee, USA), in sagittal,
coronal and axial planes, in T1- and T2-weighted fat-sat-
urated sequences, in both the preoperative and postopera-
tive evaluation of patients. This equipment was used
because it was the high-ﬁeld magnet device available at our
institution. Readers evaluated tendon integrity, presence of
complete retear, presence of abnormal areas of signal
intensity at the tendon, myotendinous junction, muscle
belly, tendon and muscle borders, bursal topography, and
presence of abnormal artifacts.
Patients with a past history of rotator cuff injury repair,
rheumatic or other connective tissue diseases, and patients
involved in work compensation were excluded.
Prior to the orthopedic procedure, after general anes-
thesia, 100 ml of bone marrow was obtained from the
posterior iliac crest with the patient in lateral recumbent
position. Bone marrow aspirates were transferred to the
state cell therapy center. BMMC fractions were obtained—
in aseptic conditions, according to Good Manufacturing
Practices—by Ficoll–Hypaque density gradient and then
resuspended in saline solution enriched with 10% autolo-
gous serum to a ﬁnal volume of 10 ml. Final cell viability,
as determined by trypan blue, was above 90%. To conﬁrm
the bone marrow origin of the cells, an aliquot of the ﬁnal
suspension was submitted to ﬂow cytometry analysis for
the presence and counting of CD34, CD45 and CD38 cells
in a 3-color FacsCalibur BD ﬂow cytometer (Becton–
Dickinson, San Jose, CA). The median concentration
of CD34? and mononuclear cells was 5.65 9 10
6 and
3.81 9 10
8, respectively.
During preparation of the mononuclear cell suspension,
the patient was placed in the beach-chair position and
surgery was initiated. Incision was performed using the
transdeltoid lateral approach. All patients underwent
acromioplasty for an increase in the subacromial space.
Tendon–tendon and tendon–bone sutures were performed
with Ethibond 5/0. After closure of the lesion, 10 ml of the
cell concentrate was injected in the tendon and bone par-
ticipating in the ‘‘footprint’’. After closure, the patient was
immobilized in a sling for 4 weeks. All patients were
operated by the same surgeon with the same surgical
technique. Physical therapy was initiated after the fourth
week in a conventional rehabilitation protocol.
The following outcomes were assessed: functional status
(UCLA score), tendon healing, and rate of rotator cuff
retear.
All patients underwent functional evaluation both before
and after surgery using UCLA scores [19]. This is an
objective rating scale with adequate validity and repro-
ducibility that assesses pain, function, range of motion,
strength, and patient satisfaction. Pain and function may
reach a maximum score of 10, whereas other components
may reach a maximum value of 5. The overall score may
reach 35. Higher scores indicate better function of the
shoulder.
This study was approved by the Research Ethics Com-
mittee (IRB-equivalent) of the appropriate institution. All
patients provided informed consent.
Results
Of the 14 patients (9 women, 5 men, mean age of
59.2 years) with rotator cuff tears who entered the study, 5
had injuries to 3 tendons with fatty inﬁltration grade II or
higher (Goutallier classiﬁcation of fatty inﬁltration) [18], 8
patients had injuries to 2 tendons, with fatty inﬁltration
grade II or higher in 5, and 1 patient had injury to 1 tendon.
Mean preoperative UCLA score was 12 (standard devia-
tion, 3.0; range, 7–16). After a minimum of 12-month
follow-up period, the UCLA score increased to a mean 31
(standard deviation ± 3.2; range, 26–35), which is con-
sidered to be a good score.
MRI analysis after a 12-month follow-up period dem-
onstrated tendon integrity in all cases (14/14), presence of
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and distal muscle belly in 8 cases (8/14), and high-intensity
blooming small round artifact at the bursal and tendon
topography in 11 cases (11/14). Six patients (6/14) showed
formation of a high-signal intensity zone at the critical
zone. None of these ﬁndings affected the ﬁnal functional
result (Fig. 1).
The time frame of 12 months was chosen because most
papers in the literature mention the ﬁrst year as the period
during which the majority of the retears occur. Neverthe-
less, our ﬁndings remained stabilized at the end of the
second postoperative year in all but one patient, who
relapsed into pain and loss of strength, requiring a new
surgical procedure.
Discussion
The most important ﬁndings of the present study were the
positive results associated with implantation of mononu-
clear autologous stem cells following rotator cuff sutur-
ing. Our results showed that the procedure is safe and
provides better functional outcomes than would usually be
expected for such lesions. Many patients undergoing
rotator cuff repair surgery show advanced degeneration of
the tendons, which are thinner and atrophic, probably
explaining why negative results are so often reported in
the literature, with frequent postoperative complications,
especially retear [2, 25]. A number of researchers have
shown, with either MRI or ultrasound, that tendon
degeneration continues even after surgery [31]. Although
tendon quality during suturing is essential for a successful
treatment, this is one of the factors that we have not yet
been able to change.
Despite all new technologies developed and incorpo-
rated into the surgical treatment of rotator cuff tears, there
is no consistency in the literature with regard to outcomes
of patients with large or massive injuries. According to
several authors [4, 9, 14, 22, 28, 37], the 75% threshold of
good results is not exceeded in this type of injury. Such
failure is attributed not to technical limitations of the
methods currently used, but to the poor quality of the
treated tissue, i.e., rotator cuff tendons degenerated by
intrinsic and extrinsic factors.
As both open surgery and arthroscopic surgery have
exceeded the time required to overcome the learning curve,
we cannot expect any changes to occur before the concepts
and paradigms of conventional technology are changed.
Therefore, the natural way to seek better results should
necessarily shift its focus from tissue therapy to cell therapy
[7, 26, 30, 35].
Over the last few years, the use of BMMC in the
treatment of degenerative diseases has been extensively
investigated. Studies have been conducted in cardiology
[1], neurology [38], dentistry [32], and so forth. There are,
however, few publications in the orthopedic ﬁeld [2–5]
addressing the use of BMMC in the recovery of tendons in
rotator cuff tears.
Fig. 1 Preoperative coronal
T2-weighted magnetic
resonance image (MRI)
showing complete injury with a
3-cm retraction in 2 patients
(a, b). Coronal T1-weighted
(c) and T2-weighted (d) MRI
sequences showing
postoperative ﬁndings with
tendons repaired, blooming
artifacts at footprint, high-
intensity tissue at the footprint
(c), and high-intensity tissue at
tendon–bursa interface (d)
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123It has recently been suggested that, in addition to the
skin, intestine and bone marrow, other tissues and organs—
liver, pancreas, skeletal muscle (associated with the loco-
motor system), adipose tissue and nervous system—have a
stock of tissue-speciﬁc stem cells albeit with a limited
capacity to regenerate after signiﬁcant injury [2, 6]. As for
the muscle–skeletal system, in 1998, Ferrari et al. [12]
were the ﬁrst to describe the role of adult stem cells in
tissue regeneration. The authors noted that genetically
marked bone marrow cells injected into (chemically dam-
aged) muscles of genetically immunodeﬁcient mice were
able to differentiate into muscle cells, thus reducing the
injury. In another experiment, instead of injecting bone
marrow cells directly into the muscle injury, immunodeﬁ-
cient mice received a bone marrow transplant [12]. Fol-
lowing transplantation, the authors found that the infused
cells (genetically marked and therefore identiﬁable as
belonging to the donor animal) migrated to the injured
muscle area, suggesting that adult bone marrow stem cells
are able to migrate to injured areas and differentiate into
skeletal muscle cells. The aforementioned studies estab-
lished two new important ideas: BMMC can give rise to
skeletal muscle cells and can migrate to damaged areas in
the muscle.
Other tendon diseases develop in a very similar way to
rotator cuff injuries. Quadriceps and patellar tendinopathy,
as well as epicondylitis (tennis elbow), behave similarly
with respect to the development of tendon degeneration
[11, 27]. In these diseases, new treatments have gained
ground trying to stimulate tendon regeneration, including
shockwave therapy [13], microtenotomy, and thermal
stimulation [5, 39]. Their purpose is to cause ‘‘controlled
damage’’ to the tendon in order to stimulate repair of the
tendon structure via inﬂammatory reaction, i.e., recruit-
ment of cells and angiogenesis. However, considering the
replication and differentiation abilities of stem cells, one
could assume that, if placed in a tissue such as a tendon,
they could also stimulate its regeneration, similar to what is
observed in other tissues. We decided to implant BMMC
into the sick tendon, expecting to obtain greater stimulus
for tendon tissue repair, by creating a healthier and more
resilient set. When the use of BMMC was contemplated,
there was no certainty about the results that could be
obtained. However, the outcomes observed during post-
operative functional and imaging assessment exceeded
even the most optimistic expectations.
Conversely, a surprising ﬁnding was that some signal
changes went beyond usual patterns of visualization of the
tendons in MRI evaluation. The ﬁndings of areas of low
signal in T1- and T2-weighted sequences at the supraspi-
natus distal belly and tendon borders called the readers’
attention and were thought to correspond to hemosiderin
accumulation, both because of the signal characteristics
and because of the similarity with hemosiderin deposits in
other entities, e.g., hemophilia and synovial pigmented
vilonodular synovitis (PVNS). In turn, areas of T2 hyper-
intensity at the tendon’s critical zone were thought to
correspond to new tissue formation (regenerated tendon). It
is, of course, not possible to specify the type of newly
formed tissue, once we did not perform biopsy or histo-
logical analysis after surgery. Nevertheless, we can con-
clude that this newly formed tissue has some quality. Also,
the presence of prominent blooming artifacts at the surgical
site called the readers’ attention and was thought to cor-
respond to some kind of reaction of the tissue exposed to
BMMC implantation. Although our study did not include
controls and although our MRI analysis was based on
subjective criteria, those 3 MRI ﬁndings really called
readers attentions.
With regard to study limitations, it is necessary to point
out that the procedures were not blind to patients and sur-
geon; therefore, the possibility of a biased result (Haw-
thorne effect) in the clinical and functional assessment
cannot be ruled out. In addition, because cell therapy is
frequently portrayed by the media as a redeeming treatment
option, it is possible that such an environment, combined
with unconscious stimulation on the part of evaluators, has
inﬂuenced patients’ opinions and therefore affected the
quality of ﬁnal results. Notwithstanding, the use of BMMC
in tendon injuries may ﬁll an important therapeutic gap that
still exists today, despite all available technologies. Finally,
although the initial results of this study have exceeded our
expectations, further investigation into the topic, especially
with larger samples, is yet to be conducted.
Conclusion
Patients undergoing sutures for rotator cuff tear associated
with BMMC implantation in our sample presented prom-
ising results when compared with historical data available
for patients undergoing the same surgical procedure with-
out the addition of stem cells. Our preliminary results
indicate that the procedure is safe and therefore reinforce
the importance of further research to better investigate the
use of this biological approach to enhance tissue quality in
affected tendons.
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